Research and Markets has announced the addition of the "Global Infantile Spasms Therapeutics Market 2017-2021" report to their offering.
The report forecasts the global infantile spasms therapeutics market to grow at a CAGR of 10.16% during the period 2017-2021.
The onset of infantile spasm is usually found in the first year of life between four months and eight months of age. The condition constitutes 2% of childhood epilepsies and 25% of epilepsies with onset in the first year of life. There are around 2,000-4,000 new cases observed in the US each year. The overall long-term prognosis for infantile spasms patients is poor. It has been found that 50%-70% of infantile spasms patients develop other seizure types and 18%-50% will develop Lennox-Gastaut syndrome (LGS) or other forms of symptomatic generalized epilepsy.
The report covers the present scenario and the growth prospects of the global thoracic surgery market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of infantile spasms therapuetics.
Key Questions Answered in this Report:
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Key Vendors:
- H. Lundbeck
- Mallinckrodt Pharmaceuticals
- INSYS Therapeutics
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Infantile spasm: Overview
Part 06: Market landscape
Part 07: Market segmentation by dosage form
Part 08: Market segmentation by ROA
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/mkj2kv/global_infantile
View source version on businesswire.com: http://www.businesswire.com/news/home/20170113005322/en/